This study aims to investigate whether inducing transdifferentiation in pancreatic cancer cells can reduce malignancy, focusing on the role of the transcription factor NeuroD1 and its regulatory pathways. The gene discussed is NEUROD1; the disease is familial pancreatic carcinoma.